If Brainchip is apparently a cutting-edge tech/AI/chip stock, you have to ask yourself why their R&D spend is so light on. For the half year ended 30 June 2024 they spent US$5.7M on sales, marketing and general expenses, and just US$4.4M on R&D. The sales and marketing is particularly hard to justify because by their own admission Akida 1.0 wasn't good enough to displace incumbents.
If you're a shareholder with a functioning brain it's probably worth going back to January 2023 and reading the first few paragraphs of each quarterly report released between then and now, noting how hard the company was pushing the line about how they were getting the "highest ever level of commercial engagements" etc. Then take a look at revenues, from US$116K down 8% to US$107K. Then take a look at what Key Management Personnel pay themselves each year, and you will be well armed with a few facts to figure out who is getting taken for a ride here.
That is some proper 'Fact Finding'.
BRN Price at posting:
18.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)